Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis
Myocardial ischemia-reperfusion injury (MIRI) is a phenomenon that reperfusion leads to irreversible damage to the myocardium and increases mortality in acute myocardial infarction (AMI) patients. There is no effective drug to treat MIRI. Tubeimoside I (TBM) is a triterpenoid saponin purified from C...
Saved in:
Main Authors: | Dingyi Lv, Minghao Luo, Zhe Cheng, Ruiyu Wang, Xiyang Yang, Yongzheng Guo, Longxiang Huang, Xiang Li, Bi Huang, Jian Shen, Suxin Luo, Jianghong Yan |
---|---|
Format: | article |
Language: | EN |
Published: |
Hindawi Limited
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/82ba79d8f78a476e9e08e9266c8d402b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy
by: Yani Wang, et al.
Published: (2021) -
Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury
by: Xinye Li, et al.
Published: (2021) -
Ubiquitin-Specific Protease 29 Exacerbates Cerebral Ischemia-Reperfusion Injury in Mice
by: Jia-Bao Hou, et al.
Published: (2021) -
Mitochondrial Transplantation Attenuates Cerebral Ischemia-Reperfusion Injury: Possible Involvement of Mitochondrial Component Separation
by: Qiang Xie, et al.
Published: (2021) -
DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis
by: Xiaoyong Zhao, et al.
Published: (2021)